A month after it opened an investigation into the alleged dumping of MDI from China on the U.S. market, the U.S. International Trade Commission (USITC) has determined there is justification to continue investigations.
After looking at imports into the country during the second half of 2024, USITC has decided there are reasonable grounds to consider that U.S. industry is materially injured by reason of imports of MDI from China that are allegedly sold in the U.S. at less than fair value from China. This follows a petition from the Ad Hoc MDI Fair Trade Coalition asking for antidumping duties to be imposed on U.S. MDI imports from China.
Chair Amy Karpel and commissioners David Johanson and Jason Kearns voted in favour of further investigations. A preliminary antidumping duty ruling is set for July 22.
Methylene Diphenyl Diisocyanate from China, a public report by the Commission, will be available by May 5 on the USITC website.
In 2024, the U.S. imported about 229kT of MDI from China. This is currently subject to a 35 percent tariff, with an additional 10 percent being imposed at the start of February on top of the 25 percent introduced in May 2019. Very little MDI goes in the other direction, where it faces a 25 percent tariff plus the regular 6.5 percent import duty.